CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• OP. Inc. Y/Y Annual
Panbela Therapeutics Inc   (PBLA)
Other Ticker:  
 
 

PBLA's Operating Income Growth by Quarter and Year

Panbela Therapeutics Inc 's Operating Income results by quarter and year




PBLA Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -5.18 -3.33 -1.59
III Quarter September -7.85 -3.62 -2.21 -2.00
II Quarter June -5.88 -21.29 -2.23 -1.10
I Quarter March -4.86 -4.00 -2.25 -1.07
FY   -18.59 -34.09 -10.02 -5.76



PBLA Operating Income third quarter 2023 Y/Y Growth Comment
Panbela Therapeutics Inc in the third quarter 2023 recorded Operating Loss of $ -7.85 millions.

According to the results reported in the third quarter 2023, Panbela Therapeutics Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Panbela Therapeutics Inc ' s Operating Income no change of % ranks overall at the positon no. in the third quarter 2023.

Explain Operating Income growth


PBLA Operating Income ( Y/Y Growth %) 2023
 2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Panbela Therapeutics Inc 's third quarter 2023 Operating Income $ -7.85 millions PBLA's Income Statement
Panbela Therapeutics Inc 's third quarter 2022 Operating Income $ -3.62 millions Quarterly PBLA's Income Statement
New: More PBLA's historic Operating Income Growth >>


PBLA Operating Income (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -


Compare PBLA Profitability >> Back to PBLA Growth rate Comparisons >>


Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Panbela Therapeutics Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PBLA's III. Quarter Q/Q Operating Income Comment
Recent Operating Loss of -7.85 millions by Panbela Therapeutics Inc appear even less good if you take a look at -5.88 millions Operating Loss in the second quarter.

Within Major Pharmaceutical Preparations industry Panbela Therapeutics Inc achieved highest sequential Operating Income growth. While Panbela Therapeutics Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PBLA's III. Quarter Q/Q Operating Income Comment
Current accomplishment of -7.85 millions by Panbela Therapeutics Inc come out even more unfavourable compare to the Operating Loss -5.88 millions a quarter before.

Within Major Pharmaceutical Preparations industry Panbela Therapeutics Inc achieved highest sequential Operating Income growth. While Panbela Therapeutics Inc 's Operating Income growth quarter on quarter, overall rank is .


Panbela Therapeutics Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Sep 30 2022)
Cumulative Operating Income 12 Months Ending $ -23.76 $ -19.54 $ -34.95 $ -34.09 $ -32.24
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #

New: More PBLA's historic Operating Income Growth >>



Cumulative Operating Income growth Comment


Panbela Therapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Panbela Therapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
PBLA's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for PBLA's Competitors
Operating Income Growth for Panbela Therapeutics Inc 's Suppliers
Operating Income Growth for PBLA's Customers

You may also want to know
PBLA's Annual Growth Rates PBLA's Profitability Ratios PBLA's Asset Turnover Ratio PBLA's Dividend Growth
PBLA's Roe PBLA's Valuation Ratios PBLA's Financial Strength Ratios PBLA's Dividend Payout Ratio
PBLA's Roa PBLA's Inventory Turnover Ratio PBLA's Growth Rates PBLA's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2023
Viemed Healthcare Inc 186.32%$ 186.317 millions
Penumbra Inc132.33%$ 132.333 millions
Alpha Pro Tech Ltd 119.94%$ 119.938 millions
Collegium Pharmaceutical inc 119.93%$ 119.930 millions
Docgo Inc 107.37%$ 107.372 millions
Eli Lilly And Company104.32%$ 104.324 millions
Boston Scientific Corporation93.58%$ 93.575 millions
Pro dex Inc 92.95%$ 92.947 millions
Merit Medical Systems Inc88.33%$ 88.331 millions
Infusystem Holdings Inc79.96%$ 79.958 millions
Amneal Pharmaceuticals Inc 70.56%$ 70.559 millions
Fonar Corporation68.01%$ 68.013 millions
Integer Holdings Corporation64.31%$ 64.314 millions
Cadre Holdings inc 62.18%$ 62.183 millions
Progyny Inc 61.61%$ 61.608 millions
Neurocrine Biosciences Inc 60.82%$ 60.820 millions
Davita Inc 59.06%$ 59.063 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com